GenRe-Mekong Forum 2023: Malaria-endemic countries discuss genetic surveillance data and control strategies

Engaging presentations and informative experience-sharing between malaria endemic countries generated discussions on the genetic surveillance of drug resistant Plasmodium falciparum strains in the GMS and development of other use cases – all invaluable for informing current and future strategies.

Funded by the Bill & Melinda Gates Foundation (BMGF) and the Global Fund (GF), GenRe-Mekong is a large network for molecular surveillance of antimalarial drug resistance and molecular epidemiology of falciparum malaria in the GMS that provides NMCPs with frequent full reports on the epidemiology of malaria, including maps of drug resistance prevalence, and molecular surveillance integrated in the malaria elimination efforts funded by RAI, a large regional malaria GF grant.

“It was a pleasure to participate, meet the country representatives, and learn about the wonderful malaria genomic surveillance work being conducted in the GMS. It was also great to hear about the work of your international collaborators from Australia, Mozambique, Kenya, Ghana and the UK, many of whom are also BMGF grantees,” Dr Estee Torok, Senior Program Officer, Global Health – Malaria, Bill & Melinda Gates Foundation